Holdings of the Fund as of 6/28/2024
Total Number of Holdings (excluding cash): 51
Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
55,832 |
$1,562,179.36 |
7.64% |
AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
8,423 |
$1,444,712.96 |
7.07% |
Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
11,663 |
$1,443,879.40 |
7.06% |
Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
9,189 |
$1,343,064.24 |
6.57% |
Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
29,220 |
$1,213,506.60 |
5.94% |
United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
2,978 |
$948,641.90 |
4.64% |
Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
984 |
$890,893.92 |
4.36% |
Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
2,708 |
$846,114.60 |
4.14% |
Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
1,762 |
$825,884.64 |
4.04% |
Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
767 |
$806,140.01 |
3.94% |
Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
3,417 |
$792,128.94 |
3.88% |
Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
10,284 |
$705,585.24 |
3.45% |
Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
6,621 |
$650,976.72 |
3.18% |
Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,738 |
$648,019.68 |
3.17% |
Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
59,939 |
$637,151.57 |
3.12% |
Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
29,349 |
$607,524.30 |
2.97% |
Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
5,472 |
$584,026.56 |
2.86% |
Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,739 |
$359,242.62 |
1.76% |
Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
6,414 |
$335,837.04 |
1.64% |
Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
745 |
$306,828.25 |
1.50% |
Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
9,494 |
$243,805.92 |
1.19% |
Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
3,567 |
$216,231.54 |
1.06% |
Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
7,750 |
$186,775.00 |
0.91% |
Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
8,083 |
$181,625.01 |
0.89% |
Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,287 |
$177,181.29 |
0.87% |
Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
2,339 |
$161,040.15 |
0.79% |
Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
10,309 |
$148,758.87 |
0.73% |
Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
810 |
$127,980.00 |
0.63% |
Merus NV |
MRUS |
N5749R100 |
Biotechnology |
2,136 |
$126,387.12 |
0.62% |
Blueprint Medicines Corporation |
BPMC |
09627Y109 |
Pharmaceuticals |
1,107 |
$119,312.46 |
0.58% |
Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
649 |
$119,182.36 |
0.58% |
Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
2,291 |
$109,189.06 |
0.53% |
TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
6,014 |
$106,989.06 |
0.52% |
Arcellx, Inc. |
ACLX |
03940C100 |
Biotechnology |
1,883 |
$103,922.77 |
0.51% |
Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
991 |
$103,440.58 |
0.51% |
Intra-Cellular Therapies, Inc. |
ITCI |
46116X101 |
Biotechnology |
1,490 |
$102,050.10 |
0.50% |
BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
1,200 |
$98,796.00 |
0.48% |
Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
2,385 |
$97,928.10 |
0.48% |
Roivant Sciences Ltd. |
ROIV |
G76279101 |
Biotechnology |
9,052 |
$95,679.64 |
0.47% |
MoonLake Immunotherapeutics (Class A) |
MLTX |
61559X104 |
Biotechnology |
2,147 |
$94,403.59 |
0.46% |
Nuvalent, Inc. (Class A) |
NUVL |
670703107 |
Biotechnology |
1,231 |
$93,383.66 |
0.46% |
IDEAYA Biosciences, Inc. |
IDYA |
45166A102 |
Biotechnology |
2,317 |
$81,349.87 |
0.40% |
Ultragenyx Pharmaceutical Inc. |
RARE |
90400D108 |
Biotechnology |
2,002 |
$82,282.20 |
0.40% |
Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
1,800 |
$76,050.00 |
0.37% |
ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
4,456 |
$72,410.00 |
0.35% |
Kymera Therapeutics, Inc. |
KYMR |
501575104 |
Biotechnology |
2,425 |
$72,386.25 |
0.35% |
Viking Therapeutics, Inc. |
VKTX |
92686J106 |
Biotechnology |
1,344 |
$71,245.44 |
0.35% |
CRISPR Therapeutics AG |
CRSP |
H17182108 |
Biotechnology |
1,230 |
$66,432.30 |
0.32% |
Beam Therapeutics Inc. |
BEAM |
07373V105 |
Biotechnology |
2,622 |
$61,433.46 |
0.30% |
Arvinas, Inc. |
ARVN |
04335A105 |
Biotechnology |
2,252 |
$59,948.24 |
0.29% |
US Dollar |
$USD |
|
Other |
29,140 |
$29,139.53 |
0.14% |
GRAIL, Inc. |
GRAL |
384747101 |
Biotechnology |
165 |
$2,536.06 |
0.01% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|